This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Commonwealth Scientific and Industrial Research Organisation, Peter Maccallum Cancer Institute. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,355 
1 out of 19 Years Active: 2010-2011
Title: Celebrating the Innovations of Susan Kaye Nilsson
Introduction
Susan Kaye Nilsson, a prominent inventor based in East Bentleigh, Australia, has made significant contributions to the field of hematopoietic stem cell research. With a total of two patents to her name, Nilsson has dedicated her career to advancing medical science, particularly in the areas of cell selection and culture techniques.
Latest Patents
Nilsson's recent patents focus on groundbreaking methods in the selection and cultivation of hematopoietic stem cells (HSCs). One of her patents outlines a method for selecting HSCs by utilizing an agent that binds to the α9β1 integrin present on the cell surface, which allows for the separation of HSCs based on this binding. Additionally, her invention provides a system to culture these cells while inhibiting their differentiation, thereby producing a population of lineage-committed cells.
Her second patent focuses on identifying hematopoietic stem cells based on specific cell surface markers. This method includes obtaining a cell sample and detecting the presence of distinctive carbohydrate sequences. These breakthroughs not only enhance the understanding of HSCs but also pave the way for developing improved therapies in regenerative medicine.
Career Highlights
Throughout her career, Susan Kaye Nilsson has been associated with leading institutions such as the Peter MacCallum Cancer Institute and the Commonwealth Scientific and Industrial Research Organisation. These positions have allowed her to contribute substantially to the advancement of cancer treatment and stem cell research.
Collaborations
Nilsson has worked alongside esteemed colleagues such as David Norman Haylock and Paul J Simmons, fostering a collaborative environment that encourages innovation and excellence in scientific research. Their combined efforts have undoubtedly enriched the development of methodologies related to stem cell identification and cultivation.
Conclusion
Susan Kaye Nilsson's work exemplifies a commitment to innovation and research in the field of hematopoietic stem cells. Her patents not only reflect her expertise but also contribute to the broader scientific community's understanding and capabilities. As she continues her research, her contributions hold the potential to revolutionize treatments in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile